Sara Jeevanjee, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 6
- 3 carriers
- Offices
- 2
- Since medical school
- 17 years
- Temple University School of Medicine, 2009
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
6 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jeevanjee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
6 of 6 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A114753 · Current
Licensed to practise in California · since 2010 · expires 2028-10-31 · Temple University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Preventive Medicine - Addiction Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$252,487 in 2024
Medicaid paid $252,487 for 4,241 billed services this clinician did in 2024, up to 75 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 759 | $251,183 |
| Short return visit (20+ min) | 840 | $996 |
| Return visit (30+ min) | 218 | $300 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 15 | $8 |
| Pain severity quantified; pain present (COA) (ONC) | 36 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 144 | $0 |
| Medication list documented in medical record (COA) | 437 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 48 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 496 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 84 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 233 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 438 | $0 |
| 2024 | 4,241 | 14 | 75 | $252,487 |
| 2023 | 6,023 | 14 | 175 | $463,734 |
| 2022 | 3,261 | 13 | 120 | $260,774 |
| 2021 | 524 | 5 | 21 | $74,939 |
| 2020 | 1,132 | 4 | 26 | $127,454 |
| 2019 | 486 | 5 | 20 | $40,643 |
| 2018 | 518 | 5 | 24 | $68,249 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,464 | $456,228 |
| Short return visit (20+ min) | 2,218 | $6,095 |
| Return visit (30+ min) | 225 | $699 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 55 | $464 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $176 |
| Short return visit | 27 | $46 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 112 | $26 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 232 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 370 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 189 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 289 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 298 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 876 | $255,432 |
| Short return visit (20+ min) | 1,111 | $3,417 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 51 | $1,132 |
| Return visit (30+ min) | 174 | $765 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 44 | $18 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 44 | $10 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 198 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 226 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 70 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 90 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 190 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 92 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 277 | $74,159 |
| Short return visit (20+ min) | 165 | $618 |
| Return visit (30+ min) | 36 | $162 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 29 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 17 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 484 | $123,629 |
| Return visit (30+ min) | 475 | $2,905 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 34 | $637 |
| Short return visit (20+ min) | 139 | $283 |
2019
| Clinic visit/encounter, all-inclusive | 147 | $35,951 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 141 | $2,483 |
| Return visit (30+ min) | 174 | $1,553 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 12 | $466 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $191 |
2018
| Clinic visit/encounter, all-inclusive | 270 | $64,342 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 166 | $2,295 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 26 | $821 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 32 | $547 |
| Return visit (30+ min) | 24 | $243 |
Drugs they prescribed that Part D paid
$130,660
Pharmacies billed $130,660 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (26 of 1,213) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 65% of their opioid prescriptions.
1,007 generic and 193 brand-name prescriptions · $130,660 in drug cost · 14 antibiotic prescriptions · 20 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 12 | $10,819 | $902 |
| Ozempic | 12 | $10,676 | $890 |
| Combivent Respimat | 18 | $8,414 | $467 |
| Eliquis | 13 | $7,350 | $565 |
| Jardiance | 11 | $5,980 | $544 |
See all 33 drugs
| Xarelto | 12 | $10,819 | $902 |
| Ozempic | 12 | $10,676 | $890 |
| Combivent Respimat | 18 | $8,414 | $467 |
| Eliquis | 13 | $7,350 | $565 |
| Jardiance | 11 | $5,980 | $544 |
| Buprenorphine | 11 | $2,832 | $257 |
| Buprenorphine-Naloxone | 18 | $2,068 | $115 |
| Albuterol Sulfate Hfa | 31 | $818 | $26 |
| Atorvastatin | 95 | $248 | $3 |
| Gabapentin | 33 | $216 | $7 |
| Tamsulosin | 32 | $163 | $5 |
| Lisinopril | 48 | $135 | $3 |
| Omeprazole | 30 | $125 | $4 |
| Bupropion Xl | 13 | $118 | $9 |
| Amlodipine Besylate-Benazepril | 11 | $114 | $10 |
| Metoprolol | 31 | $109 | $4 |
| Duloxetine | 14 | $109 | $8 |
| Hydroxyzine | 11 | $99 | $9 |
| Ibuprofen | 18 | $92 | $5 |
| Fluticasone Propionate | 14 | $88 | $6 |
| Lactulose | 14 | $87 | $6 |
| Montelukast | 16 | $85 | $5 |
| Famotidine | 27 | $85 | $3 |
| Pantoprazole | 23 | $84 | $4 |
| Furosemide | 39 | $70 | $2 |
| Quetiapine | 13 | $63 | $5 |
| Losartan | 24 | $61 | $3 |
| Levothyroxine | 11 | $54 | $5 |
| Trazodone | 15 | $54 | $4 |
| Amlodipine Besylate | 39 | $52 | $1 |
| Allopurinol | 15 | $32 | $2 |
| Cyclobenzaprine | 12 | $30 | $3 |
| Metformin | 13 | $10 | $1 |
Year by year
| 2024 | 1,213 | 173 | 2% (26) | 16% | $130,660 |
| 2023 | 637 | 107 | 2% (14) | None | $113,406 |
| 2022 | 389 | 75 | None | 22% | $58,115 |
| 2021 | 191 | 37 | None | 17% | $34,092 |
| 2020 | 367 | 51 | None | None | $31,939 |
| 2019 | 323 | 61 | None | None | $128,121 |
| 2018 | 321 | 67 | None | None | $32,722 |
| 2017 | 252 | 54 | 6% (14) | None | $25,395 |
| 2016 | 96 | 27 | None | 30% | $13,417 |
| 2014 | 16 | None | None | None | $5,434 |
| 2013 | 24 | None | None | 50% | $2,889 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Trulicity | 31 | $33,547 | $1,082 |
| Synjardy Xr | 11 | $8,203 | $746 |
| Flovent Hfa | 11 | $4,881 | $444 |
| Albuterol Sulfate Hfa | 13 | $745 | $57 |
| Oxybutynin Chloride | 20 | $660 | $33 |
| Atorvastatin | 38 | $382 | $10 |
| Metoprolol | 20 | $272 | $14 |
| Omeprazole | 18 | $271 | $15 |
| Gabapentin | 18 | $257 | $14 |
| Amlodipine Besylate | 25 | $226 | $9 |
| Mirtazapine | 13 | $217 | $17 |
| Furosemide | 35 | $188 | $5 |
| Lisinopril | 21 | $166 | $8 |
| Famotidine | 12 | $155 | $13 |
| Ibuprofen | 18 | $111 | $6 |
| Metformin | 14 | $73 | $5 |
2022: 8 drugs
| Atorvastatin | 49 | $404 | $8 |
| Gabapentin | 16 | $237 | $15 |
| Furosemide | 24 | $152 | $6 |
| Omeprazole | 17 | $124 | $7 |
| Famotidine | 11 | $81 | $7 |
| Amlodipine Besylate | 20 | $73 | $4 |
| Lisinopril | 15 | $53 | $4 |
| Metformin | 11 | $48 | $4 |
2021: 2 drugs
| Atorvastatin | 26 | $199 | $8 |
| Furosemide | 12 | $43 | $4 |
2020: 9 drugs
| Metoprolol | 21 | $259 | $12 |
| Atorvastatin | 28 | $199 | $7 |
| Tamsulosin | 17 | $143 | $8 |
| Gabapentin | 12 | $141 | $12 |
| Furosemide | 26 | $108 | $4 |
| Ibuprofen | 11 | $91 | $8 |
| Amlodipine Besylate | 16 | $89 | $6 |
| Trazodone | 11 | $58 | $5 |
| Lisinopril | 15 | $45 | $3 |
2019: 6 drugs
| Ozempic | 12 | $9,097 | $758 |
| Xarelto | 11 | $8,478 | $771 |
| Suboxone | 12 | $2,272 | $189 |
| Gabapentin | 16 | $183 | $11 |
| Atorvastatin | 15 | $161 | $11 |
| Lisinopril | 17 | $57 | $3 |
2018: 3 drugs
| Atorvastatin | 24 | $231 | $10 |
| Omeprazole | 15 | $103 | $7 |
| Furosemide | 13 | $49 | $4 |
2017: 4 drugs
| Suboxone | 11 | $1,641 | $149 |
| Atorvastatin | 18 | $161 | $9 |
| Gabapentin | 11 | $86 | $8 |
| Amlodipine Besylate | 12 | $41 | $3 |
Professional record
- NPI
- 1831426691
- Licence
- CA A114753California A114753: Current · expires 2028-10-31
- Trained
- Temple University School of Medicine, 2009 · 17 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1701 Divisadero St, Ste 500, San Francisco, CA, 94115
- NPI first listed
- 2009-11-14
- NPI last updated
- 2023-11-08
- NPI record certified
- 2023-11-08
This is when the NPI record was last certified, not a medical board exam.